Last $18.67 USD
Change Today -0.29 / -1.53%
Volume 316.8K
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven Kafka Ph.D.

Chief Operating Officer, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

45$1,127,369
As of Fiscal Year 2013

Background*

Dr. Steven J. Kafka, also known as Steve, Ph.D. serves as the Chief Operating Officer of Foundation Medicine, Inc. Dr. Kafka has broad responsibility for business development and operational functions. He has been the Chief Financial Officer at Aileron Therapeutics Inc., since October 2009 and also its Chief Operating Officer since June 2011. He leads Aileron's strategic and operational finance activities, directs corporate communications, human resources, and operations ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Harvard University
BA
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

Salary$336,825
Total Annual Compensation$336,825

Stock Options*

Exercisable Options10,156
Exercisable Options Value$176,540
Unexercisable Options202,344
Unexercisable Options Value$3,816,210
Total Value of Options$3,992,750
Total Number of Options212,500

Total Compensation*

Total Annual Cash Compensation$469,825
Total Short Term Compensation$336,825
Total Calculated Compensation$1,127,369
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $18.67 USD -0.29

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Samuel D. Riccitelli Chief Executive Officer, President and Director
Signal Genetics, Inc.
$450.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.